Literature DB >> 19427315

A fast and robust method to clone and functionally validate T-cell receptors.

Katrin Birkholz1, Christian Hofmann, Stefanie Hoyer, Birgit Schulz, Thomas Harrer, Eckhart Kämpgen, Gerold Schuler, Jan Dörrie, Niels Schaft.   

Abstract

Sequencing, cloning and functional testing of T-cell-receptor (TCR) alpha- and beta-chains from T-cell clones is often required in immunotherapy and in immunological research. However, the determination of the TCR chains by a simple PCR is not possible, since, in contrast to the 3' constant domain and untranslated region (UTR), no conserved sequences are present in the 5' region. Furthermore, subsequent functional testing of cloned TCRs requires laborious cell culture experiments, often involving primary human material and time-consuming viral transduction strategies. Here we present a universal PCR-based protocol, adapted from the capswitch technology, that allows for amplification of the TCR alpha- and beta-chain mRNAs without knowledge of the TCR variable domain subtype by attaching a designed sequence to the mRNA's 5' end. Two different MelanA/HLA-A2-specific and one HIVgag/HLA-A2-specific TCR were cloned that way, and were functionally tested by a newly developed easy, fast, and low-cost method: we electroporated Jurkat T cells simultaneously with TCR-encoding RNA and an NFAT-reporter construct, and measured the activation status of the cells upon specific stimulation. The results of this assay correlated with the cytokine release, functional avidity, proliferative activity, and the ability to recognize MelanA/HLA-A2-presenting tumor cells of bulk T cells electroporated with RNA encoding the same TCR. Together these two protocols represent a rapid and low-cost tool for the identification and functional testing of TCRs of T-cell clones, which can then be applied in immunotherapy or immunological research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427315     DOI: 10.1016/j.jim.2009.05.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Functional TCR T cell screening using single-cell droplet microfluidics.

Authors:  Aude I Segaliny; Guideng Li; Lingshun Kong; Ci Ren; Xiaoming Chen; Jessica K Wang; David Baltimore; Guikai Wu; Weian Zhao
Journal:  Lab Chip       Date:  2018-12-04       Impact factor: 6.799

2.  Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.

Authors:  Aniqa Shahid; Alex Olvera; Gursev Anmole; Xiaomei T Kuang; Laura A Cotton; Montserrat Plana; Christian Brander; Mark A Brockman; Zabrina L Brumme
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

3.  A practical approach to T-cell receptor cloning and expression.

Authors:  Sébastien Wälchli; Geir Åge Løset; Shraddha Kumari; Jorunn Nergård Johansen; Weiwen Yang; Inger Sandlie; Johanna Olweus
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

4.  How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer.

Authors:  Inbal Daniel-Meshulam; Shlomo Ya'akobi; Chen Ankri; Cyrille J Cohen
Journal:  Front Immunol       Date:  2012-07-06       Impact factor: 7.561

5.  RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.

Authors:  Dennis C Harrer; Bianca Simon; Shin-Ichiro Fujii; Kanako Shimizu; Ugur Uslu; Gerold Schuler; Kerstin F Gerer; Stefanie Hoyer; Jan Dörrie; Niels Schaft
Journal:  BMC Cancer       Date:  2017-08-17       Impact factor: 4.430

6.  A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies.

Authors:  Sandra Rosskopf; Judith Leitner; Wolfgang Paster; Laura T Morton; Renate S Hagedoorn; Peter Steinberger; Mirjam H M Heemskerk
Journal:  Oncotarget       Date:  2018-04-03

7.  Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Authors:  Nadia Mensali; Marit Renée Myhre; Pierre Dillard; Sylvie Pollmann; Gustav Gaudernack; Gunnar Kvalheim; Sébastien Wälchli; Else Marit Inderberg
Journal:  Cancer Immunol Immunother       Date:  2019-06-18       Impact factor: 6.968

8.  Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.

Authors:  Jan Dörrie; Christian Krug; Christian Hofmann; Ina Müller; Verena Wellner; Ilka Knippertz; Stephan Schierer; Simone Thomas; Elke Zipperer; Dieter Printz; Gerhard Fritsch; Gerold Schuler; Niels Schaft; Rene Geyeregger
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.